Clinical Trial Update: Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235) [Phase 1]

View source ↗

Summary

A Phase 1 single-dose pharmacokinetics study of SCH 900800 in Parkinson's disease patients treated with L-DOPA was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SCH 900800

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Parkinson's Disease | Phase 1 | Status: WITHDRAWN